BRPI1015469A2 - composicao farmaceutica para tratamento do diabetes tipo 2 - Google Patents
composicao farmaceutica para tratamento do diabetes tipo 2Info
- Publication number
- BRPI1015469A2 BRPI1015469A2 BRPI1015469A BRPI1015469A BRPI1015469A2 BR PI1015469 A2 BRPI1015469 A2 BR PI1015469A2 BR PI1015469 A BRPI1015469 A BR PI1015469A BR PI1015469 A BRPI1015469 A BR PI1015469A BR PI1015469 A2 BRPI1015469 A2 BR PI1015469A2
- Authority
- BR
- Brazil
- Prior art keywords
- diabetes
- pharmaceutical composition
- treating type
- treating
- type
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Nutrition Science (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CN2010/070910 WO2010111905A1 (zh) | 2009-03-31 | 2010-03-08 | 治疗2型糖尿病的药物组合物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI1015469A2 true BRPI1015469A2 (pt) | 2016-04-26 |
Family
ID=45090818
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1015469A BRPI1015469A2 (pt) | 2010-03-08 | 2010-03-08 | composicao farmaceutica para tratamento do diabetes tipo 2 |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP2402342B1 (pt) |
| JP (1) | JP5713990B2 (pt) |
| KR (1) | KR101686265B1 (pt) |
| BR (1) | BRPI1015469A2 (pt) |
| RU (1) | RU2533560C2 (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101899048B (zh) * | 2009-05-27 | 2013-04-17 | 上海恒瑞医药有限公司 | (R)-7-[3-氨基-4-(2,4,5-三氟-苯基)-丁酰]-3-三氟甲基-5,6,7,8-四氢-咪唑并[1,5-a]吡嗪-1-羧酸甲酯的盐 |
| RU2647421C2 (ru) | 2012-12-27 | 2018-03-15 | Зентива Саглык Урунлеры Сан. Ве Тыдж. А.Ш. | Способ сухого гранулирования для получения композиций метформина в виде таблеток и его композиции |
| USD834569S1 (en) | 2017-08-08 | 2018-11-27 | Samsung Electronics Co., Ltd. | Router |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2633167A1 (en) * | 2005-12-16 | 2007-07-12 | Merck & Co., Inc. | Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with metformin |
| GB0526291D0 (en) * | 2005-12-23 | 2006-02-01 | Prosidion Ltd | Therapeutic method |
| CN101468988A (zh) * | 2007-12-26 | 2009-07-01 | 上海恒瑞医药有限公司 | 哌嗪类衍生物,其制备方法及其在医药上的应用 |
-
2010
- 2010-03-08 BR BRPI1015469A patent/BRPI1015469A2/pt not_active IP Right Cessation
- 2010-03-08 RU RU2011140785/15A patent/RU2533560C2/ru not_active IP Right Cessation
- 2010-03-08 KR KR1020117025744A patent/KR101686265B1/ko not_active Expired - Fee Related
- 2010-03-08 EP EP10758007.8A patent/EP2402342B1/en not_active Revoked
- 2010-03-08 JP JP2012502429A patent/JP5713990B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP2402342A4 (en) | 2012-09-19 |
| KR101686265B1 (ko) | 2016-12-13 |
| JP2013521223A (ja) | 2013-06-10 |
| KR20130006567A (ko) | 2013-01-17 |
| JP5713990B2 (ja) | 2015-05-07 |
| RU2533560C2 (ru) | 2014-11-20 |
| RU2011140785A (ru) | 2014-04-20 |
| EP2402342B1 (en) | 2014-08-06 |
| EP2402342A1 (en) | 2012-01-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SMT201700008B (it) | Composizione farmaceutica | |
| BRPI1008598A2 (pt) | composição farmacêutica para inalação | |
| DK3246018T3 (da) | Farmaceutisk sammensætning | |
| DK2694038T3 (da) | Farmaceutisk sammensætning | |
| DK3097925T3 (da) | Farmaceutisk sammensætning | |
| BR112014016287A2 (pt) | composto, composição farmacêutica, método para aumentar a inclusão de exon 7 de smn2, método para aumentar a quantidade de proteína, método para o tratamento de sma | |
| BRPI1004940A2 (pt) | composição farmacêutica | |
| BR112012012108A2 (pt) | composição farmacêutica compreendendo propofol | |
| BR112013015602A2 (pt) | nova composição farmacèutica | |
| BR112012004080A2 (pt) | composições farmacêuticas para tratar ibd | |
| EE201300005A (et) | Ravimkoostis | |
| BRPI1015939A2 (pt) | composição farmacêutica | |
| PT2632452T (pt) | Compostos e composições para o tratamento do cancro | |
| BR112015006512A2 (pt) | composição para tratar tecidos biológicos danificados | |
| BR112014013682A2 (pt) | composição para cuidado pessoal | |
| BR112014009889A2 (pt) | compostos dissubstituídos, compostos e composição farmacêutica | |
| CO6801718A2 (es) | Composición terapéutica para el tratamiento de glioblastoma | |
| EP2774917A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DIABETES | |
| EP2769718A4 (en) | MEDICAL COMPOSITION | |
| SMT201500005B (it) | Composizione framaceutica inalabile | |
| BRPI0917562A2 (pt) | composições farmacêuticas e métodos para estabilizar as mesmas | |
| BR112012003149A2 (pt) | composição farmacêutica | |
| BR112013015048A2 (pt) | composição para o tratamento de distúrbios metabólicos | |
| PT2571488E (pt) | Composição farmacêutica de ibuprofeno para injeção | |
| BR112013007469A2 (pt) | composições farmacêuticas antidiabéticas sólidas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law | ||
| B06F | Objections, documents and/or translations needed after an examination request according art. 34 industrial property law | ||
| B07E | Notice of approval relating to section 229 industrial property law | ||
| B08F | Application fees: dismissal - article 86 of industrial property law |
Free format text: REFERENTE A 9A ANUIDADE. |
|
| B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2504 DE 02-01-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |